MedCity News August 5, 2025
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures.
Arbital Health, a health tech company focused on value-based care, has secured $31 million in Series B funding, the company announced last week.
The San Francisco-based startup provides infrastructure for payers and providers to help them manage risk-based contracts. Its platform predicts financial outcomes, measures performance across contracts, among other services. It also offers advisory services from a team of actuaries to help clients with the creation and optimization of risk contracts.
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures....
Today's Sponsors
Today's Sponsor